Psychedelic-assisted mental health treatments cause area report

Abstract

The rise in disease burden due to mental health problems, coupled with the relative ineffectiveness of existing treatments, necessitates an exploration of novel approaches. The report advocates for psychedelic-assisted treatments, encompassing ingestion of substances like psilocybin or MDMA supervised by trained therapists. The authors consider three intervention types: treatment, research, and drug development, identifying drug development as the most promising. Funding opportunities at Multidisciplinary Association for Psychedelic Studies and Usona Institute are evaluated, leading to the recommendation of Usona’s program due to its potential for cost-effectiveness. The selection process emphasizes the distinction between non-profit evaluation and funding opportunity assessment. – AI-generated abstract.